Neurologic cytomegalovirus complications in patients with aids: Retrospective review of 13 cases and review of the literature;Complicações neurológicas causadas pelo citomegalovírus em pacientes com aids: Estudo retrospectivo de 13 casos e revisão da literature

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 52, Issue 6, 2010, Pages 305-310

  Silva, Camila Almeida ^a   de Oliveira, Augusto C Penalva ^a,b   Vilas Boas, Lucy ^c   Fink, Maria Cristina D S ^c   Pannuti, Cláudio S ^c   Vidal, José E ^a,c  

^a INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AIDS; Cytomegalovirus; Encephalitis; Human immunodeficiency virus; Polyradiculopathy

Indexed keywords

CD4 ANTIGEN; EFAVIRENZ; FOSCARNET; GANCICLOVIR; LAMIVUDINE; TENOFOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAZIL; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOMEGALOVIRUS RETINITIS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LYMPHOCYTE COUNT; MALE; MEDICAL LITERATURE; MORTALITY; POLYMERASE CHAIN REACTION; RADICULOPATHY; RETROSPECTIVE STUDY; VIRUS ENCEPHALITIS; VIRUS IDENTIFICATION;

EID: 78951483570     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652010000600004     Document Type: Article

References (34)

1. Anders HJ, Goebel FD. Cytomegalovirus polyradiculopathy in patients with AIDS. Clin Infect Dis. 1998;27:345-52.
2. Anduze-Faris BM, Fillet AM, Gozlan J, Lancar R, Boukli N, Gasnault J, et al. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients. AIDS. 2000;14:517-24.
3. Arribas JR, Storch GA, Clifford DB, Tselis AC. Cytomegalovirus encephalitis. Ann Intern Med. 1996;125:577-87.
4. Bartlett JG, Gallant JE, Pham PA. Medical management of HIV infection: 2009-2010. 15th ed. Durham: Knowledge Source Solutions; 2009. 569p.
5. Centers for Disease Control and Prevention. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. Recommendations from CDC, the National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58[RR4]:1-207.
6. Chou SW, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis. 1991;163:1229-34.
7. Cinque P, Vago L, Terreni MR, Brytting M, Marenzi R, Castagna A, et al. Diagnosis of Cytomegalovirus infection of the nervous system in AIDS by polymerase chain reaction analysis of cerebrospinal fluid. Scand J Infect Dis. 1995;99(Suppl. 1):92-4.
8. Cinque P, Baldanti F, Vago L, Terreni MR, Lillo F, Furione M, et al. Ganciclovir therapy for cytomegalovirus (CMV) infection of the central nervous system in AIDS patients: monitoring by CMV DNA detection in cerebrospinal fluid. J Infect Dis. 1995;171:1603-6.
9. Cinque P, Cleator GM, Weber T, Monteyne P, Sindic C, Gerna G, et al. Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients. J Neurovirol. 1998;4:120-32.
10. Cinque P, Bossolasco S, Bestetti A, Sala S, Pierotti C, Lazzarin A. Molecular studies of cerebrospinal fluid in human immunodeficiency vírus type 1-associated opportunistic central nervous system diseases - an update. J Neurovirol. 2002;8(Suppl. 2):122-8.
11. Collazos J. Opportunistic infections of the CNS in patients with AIDS: diagnosis and management. CNS Drugs. 2003;17:869-87.
12. Cundy KC. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin Pharmacokinet. 1999;36:127-43.
13. Enting R, de Gans J, Reiss P, Jansen C, Portegies P. Ganciclovir/foscarnet for cytomegalovirus meningoencephalitis in AIDS. Lancet. 1992;340:559-60.
14. Fletcher CV, Balfour HH Jr. Evaluation of ganciclovir for cytomegalovirus disease. DICP. 1989;23:5-12.
15. Goplen AK, Liestol K, Dunlop O, Bruun JN, Maehlen J. Dementia in AIDS patients in Oslo: the role of HIV encephalitis and CMV encephalitis. Scand J Infect Dis. 2001;33:755-8.
16. Gozlan J, Salord JM, Roullet E, Baudrimont M, Caburet F, Picard O, et al. Rapid detection of cytomegalovirus DNA in cerebrospinal fluid of AIDS patients with neurologic disorders. J Infect Dis. 1992;166:1416-21.
17. Griffiths P. Cytomegalovirus infection of the central nervous system. Herpes. 2004;11(Suppl. 2):95A-104A.
18. Kedhar SR, Jabs DA. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Herpes. 2007;14:66-71.
19. Mamidi A, De Simone JA, Pomerantz RJ. Central nervous system infections in individuals with HIV-1 infection. J Neurovirol. 2002;8:158-67.
20. Manzardo C, Del Mar Ortega M, Sued O, García F, Moreno A, Miró JM. Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era. J Neurovirol. 2005;11(Suppl. 3):72-82.
21. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy. J Neurol Neurosurg Psychiatry. 2000;69:376-80.
22. Maschke M, Kastrup O, Diener HC. CNS manifestations of cytomegalovirus infections. CSN Drugs. 2002;16:303-15.
23. Mastroianni CM, Ciardi M, Folgori F, Sebastiani G, Vullo V, Delia S, et al. Cytomegalovirus encephalitis in two patients with AIDS receiving ganciclovir for cytomegalovirus retinitis. J Infect. 1994;29:331-7.
24. McCutchan JA. Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis. 1995;20:747-54.
25. McCutchan JA. Clinical impact of Cytomegalovirus infections of the nervous system in patients with AIDS. Clin Infect Dis. 1995;21(Suppl. 2): S196-201.
26. Miller RF, Fox JD, Thomas P, Waite JC, Sharvell Y, Gazzard BG, et al. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry. 1996;61:456-60.
27. Moulignier A. Atteintes du systéme nerveux central et infection par le VIH-1. Rev Neurol (Paris). 2006;162:22-42.
28. Oliveira JF, Greco DB, Oliveira GC, Christo PP, Guimaraes MD, Oliveira RC. Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience. Rev Soc Bras Med Trop. 2006;39:146-51.
29. Portegies P, Solod L, Cinque P, Chaudhuri A, Begovac J, Everall I, et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur J Neurol. 2004;11:297-304.
30. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol. 2002;8(Suppl. 2):115-21.
31. Sadler M, Morris-Jones S, Nelson, M, Gazzard, BG. Successful treatment of cytomegalovirus encephalitis in an AIDS patient using cidofovir. AIDS. 1997;11:1293-4.
32. Shelburne SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother. 2006;57:167-70.
33. Vidal JE, Penalva de Oliveira AC, Fink MC, Pannuti CS, Trujillo JR. Aids-related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo. 2008;50:209-12.
34. Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, et al. Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antirretroiral therapy. Arch Intern Med. 1998;158:957-69.